Rivero-Juarez, AntonioFrias, MarioLopez-Lopez, Pedrode Los Angeles Risalde, MarĂaBrieva, TeresaMachuca, IsabelCamacho, AngelaMartinez-Peinado, AntonioGomez-Villamandos, Jose CarlosRivero, Antonio2023-01-252023-01-252017-01-03Rivero-Juarez A, Frias M, Lopez-Lopez P, de Los Angeles Risalde M, Brieva T, Machuca I, et al. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection? Clin Infect Dis. 2017 Apr 1;64(7):964-966http://hdl.handle.net/10668/10766Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?enHIVHepatitis CHepatitis EReactivationReinfectionAgedAntiretroviral Therapy, Highly ActiveAntiviral AgentsCoinfectionFemaleHIV InfectionsHepatitis AntibodiesHepatitis CHepatitis EHepatitis E virusHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedViral LoadVirus ActivationHepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?research article28077520open accessActivacion ViralAncianoAnticuerpos antihepatitisAntiviralesCarga ViralCoinfeccionFemeninoHumanosInfecciones por VIH10.1093/cid/cix0041537-6591https://academic.oup.com/cid/article-pdf/64/7/964/11014311/cix004.pdf